Qualco Group S.A.

AGM Information • Dec 19, 2025

Announcement

Qualco Group Extraordinary General Meeting of Shareholders December 2025

Maroussi, December 19th, 2025

Pursuant to article 4.1.1(3) of the ATHEX Rulebook, the company named "Qualco Group S.A." (hereafter the "Company") announces the following:

The Extraordinary General Meeting of the Company's shareholders, which convened on 18th December 2025, with shareholders representing 56,521,889 ordinary registered shares, namely with a quorum of 80.71% of the Company's paid up share capital, pursuant to the pertinent ballot (valid votes 56,521,889), with respect to the issues on the agenda, as set out in the invitation dated 27.11.2025,

resolved upon the following:

1st Item

The approval of the partial amendment of the use of proceeds raised through the Company's share capital increase in cash pursuant to the resolution of the Extraordinary General Meeting of 14 March 2025 and in accordance with the Prospectus approved by the Hellenic Capital Market Commission on 6 May 2025 (the "Prospectus"), as follows, for the purposes of meeting the amounts referred to under items (A), (B) and (C) in Section 17 of the Prospectus:

• with respect to Use A, the remaining unallocated amount as at 25 November 2025 of €15.9 million out of a total of €23.9 million,
• with respect to Use B, the remaining unallocated amount as at 25 November 2025 of €11.1 million out of a total of €19.1 million, and
• with respect to Use C, the remaining unallocated amount as at 25 November 2025 is €1.3 million out of a total of €4.8 million,

to the extent it is considered appropriate to channel such amounts to subsidiaries of the Company in accordance with the flexibility provided in the Prospectus for the servicing of the specific uses, these amounts shall be channeled through bond loans issued by the Company's subsidiaries and not through participation in increases of their share capital, by way of derogation from what is stated in the relevant section of the Prospectus.

It is noted that the above‑mentioned amendment represents 49.4% of the total funds raised and, taking into account the change of use decided by virtue of the decision of the Company's Board of Directors dated 4 June 2025, amounts in total to 68.6% of the total funds raised.

FOR 56,521,889 shares (80.71%)
AGAINST 0 shares (0%)

ABSTAIN 0 shares (0%)

2nd Item

The approval of the revision of the Remuneration Policy, based on the content of the Board of Directors' recommendation, dated 25.11.2025.

FOR 56,509,045 shares ( 80.69%)

AGAINST 12,844 shares (0.02%)

ABSTAIN 0 shares (0 %)

3rd Item

Pre‑approval of the remuneration of the Members of the Board of Directors and the Chairman of the Audit Committee for the year 2025, of the total amount of [€393.600]. This pre-approval of the remuneration for the year 2025 is subject to approval by the next Annual General Meeting. It is further noted that the above remuneration falls within the scope of the Company's revised remuneration policy, as in force following the approval of the amendments resolved under Item 2 above and shall be paid on a pro rata basis from the date of election of each individual as a member of the Board of Directors.

FOR 56,521,889 shares (80.71%)

AGAINST 0 shares (0%)

ABSTAIN 0 shares (0%)

There were no further announcements on other items.

Marousi, 19th December 2025

The Board of Director